Day: April 17, 2023

CALGARY, Alberta, April 17, 2023 (GLOBE NEWSWIRE) — Black Diamond Group Limited (“Black Diamond” or the “Company”) (TSX: BDI), a leading provider of space rental and workforce accommodation, today announced the timing of its 2023 first quarter earnings release and conference call/webcast. Black Diamond intends to release its 2023 first quarter results after markets close on Thursday, May 4, 2023, and hold a conference call and webcast at 9:00 a.m. MT (11:00 a.m. ET) on Friday, May 5, 2023. CEO Trevor Haynes and CFO Toby LaBrie will discuss Black Diamond’s financial results for the quarter and then take questions from investors and analysts. To access the conference call by telephone dial toll free 1-800-319-4610. International callers should use 1-604-638-5340. Please connect approximately 10 minutes prior to the beginning...

– Preclinical data support the potential for FTIs in combination with KRASG12C inhibitors and TKIs to prevent or delay emergence of adaptive resistance – – Company preparing to initiate Phase 1 dose-escalation trial (FIT-001) of KO-2806, a next-generation FTI – SAN DIEGO, April 17, 2023 (GLOBE NEWSWIRE) — Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today reported preclinical data supporting the potential use of farnesyl transferase inhibitors (FTIs) to treat various types of solid tumors in combination with targeted therapies, including KRASG12C inhibitors and anti-angiogenic tyrosine kinase inhibitors (TKIs). These data were featured in two poster presentations at the American Association for Cancer Research...

SCOTTSDALE, Ariz., April 17, 2023 (GLOBE NEWSWIRE) — Adamas One Corp. (Nasdaq: JEWL) (“Adamas One,” “Adamas” or the “Company”), The Original Lab-Grown Diamond Company™, a high-tech company that leverages proprietary technology to produce high-quality, single-crystal, Lab-Grown Diamonds for jewelry and diamond materials for industrial uses, announces today that CEO Jay Grdina will present a corporate overview at the Planet MicroCap Showcase: VEGAS 2023. The conference is being held on April 25 – 27, 2023 at the Horseshoe Hotel & Casino (formerly Bally’s) in Las Vegas, NV.Presentation Date: April 26, 2023   Time: 11:00am Pacific Time   Webcast Link: https://www.webcaster4.com/Webcast/Page/2963/47996   Mr. Grdina will be available for one-on-one meetings at the conference venue. To request a meeting...

TORONTO, Ontario, April 17, 2023 (GLOBE NEWSWIRE) — Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD; OTC: TMDIF) is providing a default status report in accordance with the alternative information guidelines set out in National Policy 12-203 – Management Cease Trade Orders (“NP 12-203”). On March 22, 2023, and as further updated on April 3, 2023, the Company announced (the “Default Announcement”) that under NP 12-203 it had applied to the Ontario Securities Commission (the “OSC”) requesting a management cease trade order (“MCTO”) be imposed in respect of the late filing of its annual financial statements, the related management’s discussion and analysis and annual information form, and the accompanying chief executive officer and chief financial officer certification for its financial year ended December 31, 2022 (collectively,...

Figure 1 Margarethental and Razorback Zones, showing assay results for recently drilled holesFigure 2 Section across Razorback Zone including scissor hole ONDD022-226 – looking northFigure 3 Section across Margarethenthal Zone including scissor hole OND022-225 – looking northHighlightsOsino announces assay results from orientation drilling at Ondundu Gold Project, Namibia Drilling campaign identifies previously unknown extensional veins New zones of mineralization intersected east of the resource, in an area never previously drilledAssays received from eight of the fifteen RC infill holes at Ondundu including:ONRC23-017: 109m @ 2.30g/t (68-177m), 5m @ 7.81g/t (50-55m) and 3m @ 7.49g/t (15-18m) ONRC23-018: 93m @ 1.24g/t (102-195m) and 13m @ 3.54g/t (42-55m) ONRC22-008: 70m @ 1.24g/t (112-182m) incl. 2m @ 7.54g/t and 20m...

– Resolved more than $68.6 Million of the debt payables reported as of December 31, 2022 – – Reduced total debt obligation by more than 60% – – Files 10-K NT with U.S. Securities and Exchange Commission, maintaining SEC timely filer status – GOLDEN, Colo., April 17, 2023 (GLOBE NEWSWIRE) — SHF Holdings, Inc., d/b/a/ Safe Harbor Financial (“Safe Harbor” or the “Company”) (NASDAQ: SHFS), a leader in facilitating financial services and credit facilities to the regulated cannabis industry, today announced that, since the beginning of 2023, it has negotiated the resolution of approximately $68.6 million in debt obligations. “Since the beginning of the year, we have been working hard to resolve the financial complexities associated with, and the debt arising from our go-public transaction,” said Sundie...

Agreement will supply Tb-161 for RAD 602, a potential first in class radiopharmaceutical for treatment of brain cancers SYDNEY, Australia, April 17, 2023 (GLOBE NEWSWIRE) — Radiopharm Theranostics (ASX:RAD, “Radiopharm” or the “Company”), a developer of radiopharmaceutical products for both diagnostic and therapeutic uses, is pleased to announce an agreement with TerThera to supply the Company with Terbium-161 (Tb-161). The Tb-161 isotope will be linked to a proprietary peptide to form RAD 602, a radiotherapeutic that is being developed by Radiopharm to target protein tyrosine phosphatase mu (PTPmu or PTPμ). PTPμ is expressed in cancer cells but has limited expression in healthy tissue. Radiopharm will initiate a Phase I dose escalating trial of RAD 602 for treatment of patients with brain cancers during the fourth quarter of calendar...

The subsidiary of AS Tallinna Sadam, OÜ TS Laevad, signed an additional agreement with the Estonian Transport Administration based on the public passenger transport service Transport Administration will order additionally up to 536 trips with the ferry Regula on Virtsu-Kuivastu line from 1 June to 31 August 2023. For the summer period additional trips, TS Laevad will earn fixed fee of EUR 910,800, plus a voyage fee of EUR 455 per each trip. The maximum total amount for additional trips is EUR 1,154,680. In 2022, there was an agreement with the Transport Administration for ordering up to 536 additional trips, and Regula made 436 trips based on demand in the period from June to August. Last year, TS Laevad earned a fixes fee of EUR 772,800 for additional trips during the summer months, plus a voyage fee of EUR 455 for each trip. The total...